About Perrigo Laboratories India Private Limited
Data last updated: 30 July 2025
Perrigo Laboratories India Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Professional, Scientific And Technical. The company has been converted to a Limited Liability Partnership (LLP). For the latest details, refer to the successor LLP entity. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 23 February 2005, the company has been in operation for over 21 years.
Registered with ROC Mumbai under CIN U24230MH2005PTC240217.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.13 Lakh. It is led by directors Sumedha Nadkar Sanjeev and James Edwin Dillard Iii.
Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: Ambernath, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹33.99 Cr, a decline of 14% compared to the previous year.
The company has a workforce of approximately 25 employees as per the latest available data. It operates as a subsidiary of Professional, Scientific And Technical.
The company is associated with 1 brand - Perrigo. As per MCA filings, the company has satisfied charges of ₹50 Lakh on record.
The company has been converted to a Limited Liability Partnership (LLP). For the most current information, refer to the successor LLP entity registered with MCA. The last known website on record is perrigo.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressBldg No. 8 Flat 004 Kailash Nagar Wadavli Section, India, Ambernath, Maharashtra, India – 421501
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited has one previous CIN (Corporate Identification Number): U24230AP2005PTC045453. The current CIN is U24230MH2005PTC240217, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2005PTC240217 | Current |
| U24230AP2005PTC045453 | Previous |
Associated Brands with Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited operates one associated brand: Perrigo. These brands represent Perrigo Laboratories India Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs, OTC pharmaceuticals, and nutritional products are manufactured and distributed. | perrigo.com |
Competitors & Alternatives of Perrigo Laboratories India Private Limited
Brands and companies operating in the same space as Perrigo Laboratories India Private Limited include Merck, Roivant Sciences, Amgen and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
Amgen
|
Developer of pharmaceutical products for treating multiple diseases | Thousand Oaks, United States, United States | 1980 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Bausch & Lomb
|
Ophthalmic pharmaceuticals and instruments are developed for eye care. | Bridgewater, United States, United States | 1853 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Novo Nordisk
|
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured. | Bagsvaerd, Denmark, Denmark | 1923 |
Sanofi
|
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas. | Paris, France, France | 1973 |
GSK
|
Developer of pharmaceuticals and vaccines for various therapeutic areas | Brentford, United Kingdom, United Kingdom | - |
Business Activity of Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Perrigo Laboratories India Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited is audited by S R Batliboi & Associates LLP for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R Batliboi & Associates LLP | Locked | Locked | Locked |
Complete auditor history for Perrigo Laboratories India Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited is currently managed by 2 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumedha Nadkar Sanjeev | Whole-Time Director | 30 Sep 2015 | 10 Years 10 Months | As last reported |
| James Edwin Dillard Iii | Director | 21 Sep 2020 | 5 Years 10 Months | As last reported |
Financials of Perrigo Laboratories India Private Limited FY 2022 filings available
Perrigo Laboratories India Private Limited reported revenue of ₹33.99 Cr (down 14.00% YoY) for FY 2022.
Ten-year financial statements for Perrigo Laboratories India Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Perrigo Laboratories India Private Limited
Shareholding and ownership data for Perrigo Laboratories India Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Perrigo Laboratories India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2014 | The Hongkong and Shanghai Banking Corporation Limited | ₹50 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited has a workforce of 25 employees as of Apr 04, 2024.
Employee and EPFO history for Perrigo Laboratories India Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Perrigo Laboratories India Private Limited
GST registrations and filing compliance for Perrigo Laboratories India Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Perrigo Laboratories India Private Limited
Credit ratings, litigation, and regulatory alerts for Perrigo Laboratories India Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Perrigo Laboratories India Private Limited
MSME payment history for Perrigo Laboratories India Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Perrigo Laboratories India Private Limited
Corporate group structure for Perrigo Laboratories India Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Perrigo Laboratories India Private Limited
MCA filings and documents for Perrigo Laboratories India Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Perrigo Laboratories India Private Limited
Recent News on Perrigo Laboratories India Private Limited
Frequently Asked Questions about Perrigo Laboratories India Private Limited
Perrigo Laboratories India Private Limited has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Perrigo Laboratories India Private Limited is a former company now converted to LLP, previously operating as a private limited company in the pharma sector based in Thane, Maharashtra, India. It was incorporated on 23 February 2005 and is registered under CIN U24230MH2005PTC240217. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Perrigo Laboratories India Private Limited is U24230MH2005PTC240217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The current directors of Perrigo Laboratories India Private Limited are:
- Sumedha Nadkar Sanjeev - Whole-Time Director
- James Edwin Dillard Iii - Director
The primary industry of Perrigo Laboratories India Private Limited is pharma. The company specifically operates in pharma contract r and d.
Perrigo Laboratories India Private Limited was incorporated on 23 February 2005. Registered with ROC Mumbai.